Isracann Biosciences Inc.

CNSX:IPOT Voorraadrapport

Marktkapitalisatie: CA$2.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Isracann Biosciences Beheer

Beheer criteriumcontroles 0/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Ajay Kaila

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO1.5yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

CEO

Ajay Kaila

1.5yrs

Tenure

Ajay Singh Kaila is Interim Chief Executive Officer of Isracann Biosciences Inc. from January 20, 2023.